Ondas: Buy the Backlog, Not the Fear - A Mid-Trade Against Overstated Dilution

Hook & thesis

Ondas is being punished for an assumption: the market expects the company to dilute heavily to fund a raft of acquisitions and manufacturing scale-up. That assumption is baked into today’s multiple, not the more concrete evidence sitting in Ondas' order book - $270M+ in orders since 06/30 and a $757M pro-forma backlog that supports a raised 2026 revenue target of $525-$550M. If Ondas can convert those wins at reasonable margins and slow the pace of share issuance, the disconnect should tighten and the stock can reprice higher.

I'm proposing a tactical long: buy at $6.90, place a protective stop at $5.50, and take profits at $10.00. The idea is to capture a mid-term re-rating as order conversion and updated financials move investor focus from hypothetical dilution back to revenue and backlog realization.

What Ondas does and why it matters

Ondas operates two businesses: Ondas Networks, which sells wireless radio systems for mission-critical industrial networks, and Ondas Autonomous Systems, which builds commercial and defense drone systems (Optimus and Scout platforms). The mix matters: Networks sells recurring connectivity solutions; Autonomous Systems sells high-ticket defense and counter-UAS platforms that can generate lumpy, high-margin contracts and follow-on recurring service revenues.

The market cares because Ondas is converting meaningful contract wins into near-term revenue. Management has publicly raised 2026 revenue guidance to a $525-$550M range on the back of a pro-forma backlog of $757M and more than $165M in new orders announced from August through 10/01/2026. Those are not promises - they're booked and announced wins that provide a concrete revenue runway.

Key numbers that drive the thesis

Why the market is focused on dilution

Two dynamics explain the pessimism. First, Ondas has been aggressive on M&A to build autonomy and counter-UAS capability; that strategy consumes cash and invites equity issuance to preserve runway. Second, trailing adjusted EBITDA losses (management reported a $51M adjusted EBITDA loss in Q2) and negative free cash flow (-$171.9M trailing) reinforce a narrative that Ondas must raise capital. The result: investors are marking the stock lower unless and until they see durability in margins and less dilution risk.

But the tangible counterpoint is the backlog and order flow. Management publicly pushed 2026 revenue much higher and disclosed specific defense and counter-UAS wins (including a $56M ESAD award and other platform deals). Those filled order books are not theoretical - they should show up in revenue and cash collection cadence over the next few quarters if execution holds.

Valuation framing

Ondas trades at an elevated multiple: roughly 19.3x EV / Sales and ~23x price / sales on guidance that already implies a big step up in top line. Those multiples reflect two things: a) very rapid revenue growth expectations and b) scarce publicly traded pure plays in defense autonomy - investors price in high future returns. That said, the current multiple also embeds a fair bit of dilution and execution risk: with negative free cash flow and ongoing M&A, investors expect equity raises, which would cap near-term upside.

My view is that the multiple need not compress further if revenue execution accelerates and management demonstrates controlled capital raises or a path to break-even adjusted EBITDA by late 2027 (management targets adjusted EBITDA profitability by Q4 2027 by earlier commentary). In short: convert the backlog and show operating leverage and the market will re-rate the stock away from dilution-centric pricing.

Catalysts (what to watch)

• Quarterly results and 2027 guidance - improved gross margins or narrower adjusted EBITDA losses would be the clearest re-rating trigger (next quarterly release).
• Order-to-revenue conversion cadence - material bookings turning into revenue and cash collection over the next 1-3 quarters.
• M&A integration updates - evidence that recent acquisitions are accretive or at least not cash-negative over the near term.
• Defense contract deliveries and milestone payments on platforms like ULTRA, IonStrike, and ESAD (timely deliveries reduce execution risk).
• Macro and competitor moves - large strategic moves by incumbents (e.g., the Motorola transaction in early October) that either validate the market or compress Ondas’ margins.

The trade plan (actionable)

Thesis: the market is overstating dilution risk and understating revenue conversion. The trade is sized for high volatility and uses a hard stop.

• Entry: $6.90.
• Target: $10.00 - a mid-term price objective that prices a partial re-rate as backlog converts and the tone on dilution eases.
• Stop loss: $5.50 - below recent short-term support and the 10-day and 20-day SMAs, minimizes a larger drawdown if the stock breaks down.
• Horizon: mid term (45 trading days). That’s long enough to capture quarterly updates and initial conversion of announced orders, but not so long as to endure multiple potential capital raises.
• Risk management: size the position so a stop at $5.50 equates to no more than 2-4% of portfolio risk. If Ondas posts an earnings miss or expands guidance for equity raises, trim or exit.

Risks and counterarguments

• Execution risk on backlog conversion. Large defense and autonomy contracts can be lumpy and technically challenging; missed deliveries or cost overruns would compress margins and cash flow.
• Dilution is real. Negative free cash flow (-$171.9M) and ongoing M&A make equity raises likely if cash collections lag. Additional dilution would depress per-share upside even if revenue grows.
• Competitive pressure and strategic deals. Large incumbents (e.g., the Motorola acquisition of D-Fend) could compress pricing or accelerate competitive consolidation, pressuring Ondas’ commercial opportunity.
• High short interest can amplify downside. With >250M shares short as of 10/15/2026 and daily short volume often exceeding 40-50% of trade, negative headlines can cascade into outsized moves lower.
• Valuation complacency. The company already trades at ~19x EV/Sales; if execution does not quickly justify that multiple, the stock can re-rate lower even with growing revenue.

Counterargument to my thesis: The market may be correctly pricing in dilution because Ondas’ cash burn and acquisition pace exceed its ability to monetize the backlog quickly; even if revenue rises, per-share economics could deteriorate materially if the company funds growth with equity. That scenario would keep the multiple depressed and could overwhelm any order-book optimism.

Conclusion and what would change my mind

Ondas presents a binary setup: either it converts a large, disclosed backlog and demonstrates improving operating leverage, or it needs to raise equity and that dilutes upside. The trade assumes the former - that the market is over-discounting order conversion and instead pricing the worst-case dilution scenario. Buy at $6.90, stop at $5.50, and target $10.00 over a mid-term (45 trading days) horizon, while watching the next quarterly release and order-to-revenue cadence closely.

I would change my view if management signals a large, imminent equity raise with material proceeds earmarked for burn rather than capex or if booked orders begin slipping materially (delays, cancellations, or missed milestones). Conversely, clear signs of narrowing adjusted EBITDA losses, timely deliveries, and modest non-dilutive financing would validate the thesis and likely accelerate the desired re-rate.

Trade summary: Long ONDS at $6.90; stop $5.50; target $10.00; horizon mid term (45 trading days); risk high. Focus on order conversion and capital strategy as the arb between fear and fundamentals.